Biomea Fusion (NASDAQ:BMEA) executives highlighted early, exploratory clinical data for icovamenib in type 1 diabetes, presenting top-line results from the company’s COVALENT-112 proof-of-concept ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A restricted ...

Adults with type 2 diabetes may have greater improvements in beta-cell function eating a ketogenic diet compared with a ...

Biomea Fusion, Inc. announced positive results from preclinical experiments showing that its investigational drug icovamenib enhances beta cell function and improves the responsiveness of human islets ...

A new study finds that the keto diet can significantly improve the function of beta cells—the specialised cells in the ...

People with type 2 diabetes on a high-fat, low-carbohydrate diet may have a better chance of reversing their diabetes than ...

SAB Biotherapeutics’ SAB-142 targets stage 2/3 type 1 diabetes, aiming to preserve beta-cell function. Click here to read my ...

More than 38 million Americans have diabetes, and more than 90 percent of them have Type 2 diabetes. Type 2 diabetes usually presents in people who are 45 or older. However, it is becoming more common ...

Following a low-carb diet may potentially help patients manage disease more effectively and reduce medication use. Study: Effects of a Carbohydrate-Restricted Diet on β-Cell Response in Adults With ...